Federico Bardazzi

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 274 publications

Screening for Eating Disorders in Psoriasis Patients: A Multicenter Cross-Sectional Study.

Screening for Eating Disorders in Psoriasis Patients: A Multicenter Cross-Sectional Study.

Journal: Psoriasis (Auckland, N.Z.)

Published: July 08, 2026

Mycosis fungoides and Leser-Trélat sign.

Mycosis fungoides and Leser-Trélat sign.

Journal: Italian journal of dermatology and venereology

Published: June 15, 2026

Hypertrophic cutaneous reaction during combined treatment for pyoderma gangrenosum.

Hypertrophic cutaneous reaction during combined treatment for pyoderma gangrenosum.

Journal: Italian journal of dermatology and venereology

Published: June 10, 2026

Exploring Rare and Atypical Forms of Psoriasis: A Narrative Review.

Exploring Rare and Atypical Forms of Psoriasis: A Narrative Review.

Journal: Journal of clinical medicine

Published: June 01, 2026

Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis.

Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis.

Journal: Dermatology and therapy

Published: April 10, 2026

Evaluation of methotrexate and its influence on serum autoantibodies against BP180 in patients with bullous pemphigoid: a pilot study.

Evaluation of methotrexate and its influence on serum autoantibodies against BP180 in patients with bullous pemphigoid: a pilot study.

Journal: Acta dermatovenerologica Alpina, Pannonica, et Adriatica

Published: March 31, 2026

Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.

Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.

Journal: Dermatology and therapy

Published: March 04, 2026

Toward the definition of moderate psoriasis: an expert opinion.

Toward the definition of moderate psoriasis: an expert opinion.

Journal: The Journal of dermatological treatment

Published: February 23, 2026

Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.

Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.

Journal: The Journal of dermatological treatment

Published: February 06, 2026

Eccrine syringofibroadenoma: description of two cases.

Eccrine syringofibroadenoma: description of two cases.

Journal: Italian journal of dermatology and venereology

Published: January 22, 2026

A Real-Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome.

A Real-Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome.

Journal: International journal of dermatology

Published: January 16, 2026

Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis).

Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis).

Journal: Dermatology and therapy

Published: December 26, 2025

Showing 1-12 of 274

Last Updated: 09/26/2026